Menu

Are All Neurodegenerative Diseases Made Equal?

The Scientist is bringing together a panel of experts to share their research, discuss current therapeutic approaches, and to offer their insights.

Jan 2, 2018
The Scientist Creative Services Team

Are All Neurodegenerative Diseases Made Equal? from thescientistllc on Vimeo.


Various neurodegenerative processes result in the development of diseases like Alzheimer’s (AD), Parkinson’s (PD), amyotrophic lateral sclerosis (ALS), and, arguably, multiple sclerosis (MS). Despite years of research, drug discovery initiatives, and promising clinical trials, these diseases remain incurable. But recent studies have suggested common mechanisms underlying these pathologies. Atypical protein assembly resulting in plaque formation is a common pathological finding in both AD and PD, while neuronal death is a primary (ALS) or secondary (MS) hallmark of disease. For a detailed look at the mechanisms that drive an array of neurodegenerative diseases, The Scientist is bringing together a panel of experts to share their research, discuss current therapeutic approaches, and offer their insights. Come engage with our panel and get the answers you seek.

Topics to be covered:

  • The molecular and mechanistic similarities and differences between neurodegenerative diseases
  • Whether primary and secondary neurodegeneration distinctions are based on biology

Meet the Speakers:

Rudolph E. Tanzi, PhD
Joseph. P. and Rose F. Kennedy Professor of Neurology
Harvard Medical School
Vice-Chair, Department of Neurology; Director, Genetics and Aging Research Unit
Massachusetts General Hospital

 

Gregory A. Petsko, DPhil
Mahon Professor, Department of Neurology and Neuroscience
Director, Appel Alzheimer’s Disease Research Institute
Weill Cornell Medicine

 

Bruce D. Trapp, PhD
Chair, Department of Neurosciences
Lerner Research Institute
Cleveland Clinic

 



 

 

 

 

 

 

 

 

 

 

April 2019

Will Car T Cells Smash Tumors?

New trials take the therapy beyond the blood

Marketplace

Sponsored Product Updates

Application of TruBIOME™ to Increase Mouse Model Reproducibility
Application of TruBIOME™ to Increase Mouse Model Reproducibility
With this application note from Taconic, learn about the effects of the microbiome on reproducibility and predictability and how TruBIOME™ helps researchers generate custom microbiota mouse models!
Getting More Consistent Results by Knowing the Quality of Your Protein
Getting More Consistent Results by Knowing the Quality of Your Protein
Download this guide from NanoTemper to learn how to identify and evaluate the quality of your protein samples!
Myth Busting: The Best Way to Use Pure Water in the Lab
Myth Busting: The Best Way to Use Pure Water in the Lab
Download this white paper from ELGA LabWater to learn about the role of pure water in the laboratory and the advantages of in-house water purification!
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu Corporation announces the release of the Nexera Ultra High-Performance Liquid Chromatograph series, incorporating artificial intelligence as Analytical Intelligence, allowing systems to detect and resolve issues automatically. The Nexera series makes lab management simple by integrating IoT and device networking, enabling users to easily review instrument status, optimize resource allocation, and achieve higher throughput.